The Commissioner For Entrance Examinations, Government of Kerala is expected to release its KEAM Result 2022 on the official website on July 25th, 2022. The expected time associated with KEAM Result 2022 Date is 05:00 pm.
Prashant Jain, the executive director and CIO of HDFC AMC shared his views on the ongoing stock market correction, the underlying opportunities, and how he...
Prime Minister Narendra Modi will also be addressing a public function at Paraunkh village in Kanpur and visiting Pathri Mata Mandir with...
Zydus said it has received approval from the US Food and Drug Administration, which allows for a site transfer and manufacturing of the drug at Jarod.
The Mumbai-based drugmaker has launched the product in the US market under an exclusive license, marketing, and distribution agreement with Slayback Pharma LLC
The acquisition will strengthen the company's India formulation business by adding a fast-growing portfolio of vitamins, minerals, supplements, and...
Comes in wake of Sebi’s guidelines to bring in uniformity in benchmark of mutual fund schemes
The approval by the USFDA is for the abbreviated new drug application (ANDA) for Lacosamide Tablets of strengths 50 mg, 100 mg, 150mg, and 200 mg.
The approval granted by the USFDA to the company's arm Glenmark Pharmaceuticals Inc, USA, is for Lacosamide tablets of strengths 50 mg, 100 mg, 150 mg, and 200...
Piramal Pharma said it is now strengthening the brand offering by introducing Tetmosol Dusting Powder and increasing its media investments subsequently.
Strategies to tackle drug-resistant strains include identification of new antibiotics or targeting the bacterial mechanisms that reduce the rate of evolution...
Covid-19: Rav and Raj Chopra, who own popular restaurant Punjabi Grill in Gravesend UK, set up the walk-in vaccine centre after their father became unwell with...
Strides Pharma Science Ltd has received approval from the US health regulator for its generic version of oseltamivir phosphate for oral suspension, used for...
Biocon Biologics, a subsidiary of biotechnology major Biocon, on Friday said the US health regulator has not approved an application for Insulin Aspart filed...
"Our policy interventions are being made based on wide consultations with all stakeholders". Speaking at inaugurating the first global innovation summit of the...
Despite the muted response to Vijaya Diagnostics IPO, the broader boom is likely to continue on the back of improved financials and the potential of the...
